文献速递鼻科小儿耳鼻咽喉

囊性纤维化肺移植患者内镜鼻窦手术时机的比较

Comparison of endoscopic sinus surgery timing in lung transplant patients with cystic fibrosis.
PubMed 文献 · Int Forum Allergy Rhinol · 2022-01-05

回顾性分析近25年同一学术医疗中心23例成人囊性纤维化肺移植后行内镜鼻窦手术(ESS)的患者,按肺移植至ESS的中位时间分为ESS早期组(12例)与ESS延迟组(11例)。ESS早期组术后12个月预计值FEV1百分比(ppFEV1)较术前显著改善(CI:0.729-11.452,p=0.030),延迟组无显著变化;早期组术后12个月FEV1及ppFEV1改善显著高于延迟组(CI:0.010-0.583,p=0.043;CI:1.240-16.692,p=0.025);早期组总抗生素疗程需求较延迟组显著减少(早期中位数-1,IQR:-1.5至-0.5 vs 延迟中位数0,IQR:0至0;p=0.027)。结论认为肺移植后较早行ESS可能改善肺功能并减轻肺部急性加重。

要点

  • ESS早期组术后12个月ppFEV1较术前显著改善(CI:0.729-11.452,p=0.030)。
  • ESS早期组术后12个月FEV1及ppFEV1改善显著高于延迟组(p=0.043;p=0.025)。
  • ESS早期组总抗生素疗程需求较延迟组显著减少(p=0.027)。

核心结论

  • 肺移植后较早行ESS可能改善囊性纤维化患者的肺功能并减轻肺部急性加重。

研究设计与样本

  • 回顾性综述,纳入同一学术医疗中心近25年所有接受ESS的成人囊性纤维化肺移植患者,共23例,按肺移植至ESS的中位时间分为ESS早期组(12例)与ESS延迟组(11例)。

主要发现

  • 两组基线人口学、手术史及肺功能特征相似。
  • ESS早期组术后12个月ppFEV1较术前显著改善(CI:0.729-11.452,p=0.030),ESS延迟组术后PFT无显著变化。
  • ESS早期组术后12个月FEV1及ppFEV1改善显著高于ESS延迟组(CI:0.010-0.583,p=0.043;CI:1.240-16.692,p=0.025)。
  • ESS早期组总抗生素疗程需求较ESS延迟组显著减少(ESS早期中位数:-1,IQR:-1.5至-0.5 vs ESS延迟中位数:0,IQR:0至0;p=0.027)。

临床怎么用

  • 作者认为肺移植后较早行ESS可能改善囊性纤维化患者的肺功能并减轻肺部急性加重。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No studies have investigated when endoscopic sinus surgery (ESS) is best performed in lung transplant patients with cystic fibrosis (CF). We sought to examine the effects of ESS timing on pulmonary health in this population. METHODS: A retrospective review of all adult lung transplant patients with CF who underwent ESS at our academic medical center over a near 25-year period was performed. Patients were split into two groups based on median time from lung transplantation to ESS. Twenty-three patients were included (12 ESS early and 11 ESS delayed). Outcomes included changes in pulmonary function tests (PFTs) from baseline, preoperative to postoperative measurements, the number and duration of hospitalizations for pulmonary exacerbations, and the number of antibiotic courses used specifically to treat pulmonary exacerbations during the 12 months before and after ESS. RESULTS: Baseline demographics, operative history, and pulmonary function characteristics were similar between groups. While the ESS early group saw significant improvement from preoperative percent-predicted FEV1 (ppFEV1 ) at 12 months postoperatively (confidence interval [CI]: 0.729-11.452, p = 0.030), there were no significant postoperative PFT changes for the ESS delayed group. Postoperative improvement in FEV1 and ppFEV1 at 12 months was significantly higher for the ESS early group relative to the ESS delayed group (CI: 0.010-0.583, p = 0.043; CI: 1.240-16.692, p = 0.025; respectively). The ESS early group had a significant reduction in the need for total antibiotic courses compared with the ESS delayed group (ESS early median: -1, interquartile range [IQR]: -1.5 to -0.5 vs. ESS delayed median: 0, IQR: 0 to 0; p = 0.027). CONCLUSION: Earlier ESS interventions following lung transplantation may improve pulmonary function and attenuate pulmonary exacerbations in CF patients.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Johnson JR, Hwang PH, Nayak JV, et al. Comparison of endoscopic sinus surgery timing in lung transplant patients with cystic fibrosis. Int Forum Allergy Rhinol. 2022. PMID: 34875144. doi:10.1002/alr.22935

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。